For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug Administration approved the opioid OxyContin for the treatment of chronic pain.
The pharmaceutical company's owners have agreed to pay US7.4 billion ($11.7 billion) and relinquish ownership of the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback